Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)
University of Connecticut
Sanford Health
Washington University School of Medicine
Osijek University Hospital